In: Diabetologia, 2015, vol. 58, no. 8, p. 1827-1835
|
In: Endocrine, 2015, vol. 48, no. 3, p. 856-862
|
In: Diabetologia, 2015, vol. 58, no. 3, p. 456-463
|
In: Cell Stress and Chaperones, 2015, vol. 20, no. 2, p. 391-395
|
In: Human Molecular Genetics, 2017, vol. 26, no. 18, p. 3453-3465
|
In: Diabetologia, 2015, vol. 58, no. 2, p. 221-232
|
In: Diabetologia, 2015, vol. 58, no. 3, p. 558-565
|
In: Pharmacology, 2020, vol. 105, no. 9–10, p. 491–504
Background: Adipose tissue inflammation occurs not only in obesity but also in aging and is mechanistically linked with age-associated diseases. Studies show that ablation of the l-arginine-metabolizing enzyme arginase-II (Arg-II) reduces adipose tissue inflammation and improves glucose tolerance in obesity. However, the role of Arg-II in aging adipose tissue inflammation is not clear....
|
In: Shock, 2020, vol. 53, no. 5, p. 653–665
Objective: Activation of the constitutive nuclear and mitochondrial enzyme poly (ADP- ribose) polymerase (PARP) has been implicated in the pathogenesis of cell dysfunction, inflammation, and organ failure in various forms of critical illness. The objective of our study was to evaluate the efficacy and safety of the clinically approved PARP inhibitor olaparib in an experimental model of...
|
In: Cells, 2020, vol. 9, no. 5, p. 1311
The roles and interactions of platelets and liver sinusoidal endothelial cells in liver regeneration are unclear, and the trigger that initiates hepatocyte proliferation is unknown. We aimed to identify the key factors released by activated platelets that induce liver sinusoidal endothelial cells to produce interleukin-6 (IL-6), a cytokine implicated in the early phase of liver regeneration....
|